SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-21-000070
Filing Date
2021-08-12
Accepted
2021-08-12 10:16:27
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgen-20210630.htm   iXBRL 10-Q 1540665
2 EX-10.1 a2021063010qex101.htm EX-10.1 53826
3 EX-10.2 a2021063010qex104.htm EX-10.2 35527
4 EX-31.1 a2021063010qex311.htm EX-31.1 11323
5 EX-31.2 a2021063010qex312.htm EX-31.2 13088
6 EX-32.1 a2021063010qex321.htm EX-32.1 9898
12 GRAPHIC image001.jpg GRAPHIC 2888
  Complete submission text file 0001590750-21-000070.txt   6830180

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20210630.xsd EX-101.SCH 44869
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20210630_cal.xml EX-101.CAL 46749
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20210630_def.xml EX-101.DEF 293612
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20210630_lab.xml EX-101.LAB 588947
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20210630_pre.xml EX-101.PRE 392564
13 EXTRACTED XBRL INSTANCE DOCUMENT mgen-20210630_htm.xml XML 937978
Mailing Address 6200 LOOKOUT RD. BOULDER CO 80301
Business Address 6200 LOOKOUT RD. BOULDER CO 80301 720.643.5200
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 211165859
SIC: 8071 Services-Medical Laboratories